WINDLASUpdated 1 Sept 2026, 3:59

Windlas Biotech Limited

WINDLASUpdated 1 Sept 2026, 3:59

Market Cap

₹2,052Cr.

Current Price

₹994

High / Low

₹1,036/697

Stock P/E

30.9

ROE12.2%

ROCE15.9%

Book Value₹275

Face Value₹5.00

Dividend Yield0.63%

About

Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product development, and commercial manufacturing of generic products, including complex generics.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	74	70	68	79	72	68	87	83	79	80	92
Inventory Days	49	62	44	38	85	55	71	84	57	63	40
Days Payable	137	120	124	117	143	53	76	98	121	138	156
Cash Conversion Cycle	-14	13	-12	0	13	70	82	69	15	6	-24
Working Capital Days	-46	-37	2	-12	3	40	86	72	32	18	14
ROCE %	—	10%	13%	18%	14%	19%	15%	14%	18%	17%	16%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 3:59

WINDLAS BIOTECH LIMITED (WINDLAS) financials — quarterly results, P&L, cash flow, balance sheet, shareholding